CRYO-CELL INTERNATIONAL, INC. (CCEL) Free cash flow
- Free cash flow · 12 months (USD): Value $6.11M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-05-31..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-05-31..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-05-31..
- Free cash flow margin · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-05-31..
Free cash flow
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $6.11M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-05-31. $6.32M − $205.78K ≈ $6.11M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | (m) | (Operating cash flow − capital spending) / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $6.32M | Cash generated by operating activities. Period ending 2026-05-31. |
| Operating cash flow / net income · 12 months | -2.56× | Operating cash flow / net income. Period ending 2026-05-31. $6.32M ÷ $-2.47M ≈ -2.56× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 6.32M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 205.78K USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 6.11M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | (m) | |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -2.47M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $6.11M | (m) | $6.32M | $205.78K | (m) | (m) | (m) | $-2.47M | (m) | (m) | (m) | -2.56× |
| 2026-02-28 | $4.94M | (m) | $5.18M | $235.49K | (m) | (m) | (m) | $-2.67M | (m) | (m) | (m) | -1.94× |
| 2025-11-30 | $5.25M | (m) | $5.48M | $230.47K | (m) | (m) | (m) | $-2.43M | (m) | (m) | (m) | -2.26× |
| 2025-08-31 | $6.18M | (m) | $6.35M | $171.60K | (m) | (m) | (m) | $-473.57K | (m) | (m) | (m) | -13.42× |
| 2025-05-31 | $5.94M | (m) | $6.26M | $318.51K | (m) | (m) | (m) | $-171.30K | (m) | (m) | (m) | -36.52× |
| 2025-02-28 | $5.31M | (m) | $7.32M | $2.01M | (m) | (m) | (m) | $128.71K | (m) | (m) | (m) | 56.89× |
| 2024-11-30 | $3.61M | (m) | $6.01M | $2.40M | (m) | (m) | (m) | $402.10K | (m) | (m) | (m) | 14.95× |
| 2024-08-31 | $3.09M | (m) | $7.20M | $4.11M | (m) | (m) | (m) | $-8.93M | (m) | (m) | (m) | -0.81× |
| 2024-05-31 | $-512.24K | (m) | $6.70M | $7.22M | (m) | (m) | (m) | $-9.30M | (m) | (m) | (m) | -0.72× |
| 2024-02-29 | $-2.13K | (m) | $6.92M | $6.92M | (m) | (m) | (m) | $-9.73M | (m) | (m) | (m) | -0.71× |
| 2023-11-30 | $2.08M | (m) | $8.92M | $6.84M | (m) | (m) | (m) | $-9.52M | (m) | (m) | (m) | -0.94× |
| 2023-08-31 | $2.91M | (m) | $8.01M | $5.10M | (m) | (m) | (m) | $2.51M | (m) | (m) | (m) | 3.19× |
| 2023-05-31 | $-4.30M | (m) | $8.75M | $13.05M | (m) | (m) | (m) | $2.29M | (m) | (m) | (m) | 3.82× |
| 2023-02-28 | $-3.19M | (m) | $8.71M | $11.90M | (m) | (m) | (m) | $2.71M | (m) | (m) | (m) | 3.22× |
| 2022-11-30 | $-3.60M | (m) | $8.57M | $12.17M | (m) | (m) | (m) | $2.77M | (m) | (m) | (m) | 3.09× |
| 2022-08-31 | $-4.66M | (m) | $7.81M | $12.47M | (m) | (m) | (m) | $1.30M | (m) | (m) | (m) | 6.02× |
| 2022-05-31 | $4.41M | (m) | $7.18M | $2.77M | (m) | (m) | (m) | $1.69M | (m) | (m) | (m) | 4.26× |
| 2022-02-28 | $4.30M | (m) | $6.77M | $2.47M | (m) | (m) | (m) | $2.22M | (m) | (m) | (m) | 3.05× |
| 2021-11-30 | $6.09M | (m) | $7.93M | $1.83M | (m) | (m) | (m) | $2.08M | (m) | (m) | (m) | 3.80× |
| 2021-08-31 | $7.63M | (m) | $9.24M | $1.60M | (m) | (m) | (m) | $3.92M | (m) | (m) | (m) | 2.36× |
| 2021-05-31 | $9.16M | (m) | $9.23M | $72.01K | (m) | (m) | (m) | $3.85M | (m) | (m) | (m) | 2.40× |
| 2021-02-28 | $8.41M | (m) | $8.51M | $104.98K | (m) | (m) | (m) | $3.63M | (m) | (m) | (m) | 2.34× |
| 2020-11-30 | $8.37M | (m) | $8.47M | $99.96K | (m) | (m) | (m) | $3.62M | (m) | (m) | (m) | 2.34× |
| 2020-08-31 | $6.44M | (m) | $6.64M | $207.35K | (m) | (m) | (m) | $3.27M | (m) | (m) | (m) | 2.03× |
| 2020-05-31 | $7.08M | (m) | $7.38M | $303.65K | (m) | (m) | (m) | $3.60M | (m) | (m) | (m) | 2.05× |
| 2020-02-29 | $6.46M | (m) | $7.08M | $620.17K | (m) | (m) | (m) | $2.70M | (m) | (m) | (m) | 2.62× |
| 2019-11-30 | $5.66M | (m) | $6.32M | $662.29K | (m) | (m) | (m) | $2.29M | (m) | (m) | (m) | 2.76× |
| 2019-08-31 | $5.42M | (m) | $5.97M | $545.21K | (m) | (m) | (m) | $2.34M | (m) | (m) | (m) | 2.55× |
| 2019-05-31 | $5.35M | (m) | $5.96M | $601.33K | (m) | (m) | (m) | $1.47M | (m) | (m) | (m) | 4.06× |
| 2019-02-28 | $5.19M | (m) | $5.43M | $241.54K | (m) | (m) | (m) | $1.95M | (m) | (m) | (m) | 2.78× |
| 2018-11-30 | $4.89M | (m) | $5.33M | $446.16K | (m) | (m) | (m) | $-854.82K | (m) | (m) | (m) | -6.24× |
| 2018-08-31 | $6.15M | (m) | $6.60M | $451.45K | (m) | (m) | (m) | $-1.07M | (m) | (m) | (m) | -6.19× |
| 2018-05-31 | $4.71M | (m) | $5.06M | $347.53K | (m) | $26.12M | (m) | $-659.33K | (m) | (m) | 18.04% | -7.67× |
| 2018-02-28 | $6.63M | (m) | $6.98M | $349.12K | (m) | $25.84M | (m) | $-701.89K | (m) | (m) | 25.67% | -9.95× |
| 2017-11-30 | $5.62M | (m) | $5.72M | $98.33K | (m) | $25.38M | (m) | $2.32M | (m) | (m) | 22.14% | 2.47× |
| 2017-08-31 | $6.07M | (m) | $6.17M | $99.56K | (m) | $24.78M | (m) | $2.45M | (m) | (m) | 24.50% | 2.52× |
| 2017-05-31 | $5.97M | (m) | $6.03M | $55.24K | (m) | $24.22M | (m) | $-851.13K | (m) | (m) | 24.65% | -7.08× |
| 2017-02-28 | $5.00M | (m) | $5.32M | $315.18K | (m) | $23.75M | (m) | $-710.94K | (m) | (m) | 21.05% | -7.48× |
| 2016-11-30 | $4.64M | (m) | $4.99M | $342.98K | (m) | $23.13M | (m) | $-1.32M | (m) | (m) | 20.08% | -3.78× |
| 2016-08-31 | $4.06M | (m) | $4.41M | $352.39K | (m) | $23.06M | (m) | $-2.35M | (m) | (m) | 17.61% | -1.88× |
| 2016-05-31 | $4.00M | (m) | $4.36M | $359.78K | (m) | $22.16M | (m) | $8.12M | (m) | (m) | 18.07% | 0.54× |
| 2016-02-29 | $4.51M | (m) | $4.62M | $115.90K | (m) | $21.40M | (m) | $7.70M | (m) | (m) | 21.07% | 0.60× |
| 2015-11-30 | $4.74M | (m) | $4.85M | $108.48K | (m) | $21.09M | (m) | $8.11M | (m) | (m) | 22.49% | 0.60× |
| 2015-08-31 | $3.02M | (m) | $3.11M | $81.73K | (m) | $20.27M | (m) | $8.03M | (m) | (m) | 14.92% | 0.39× |
| 2015-05-31 | $2.94M | (m) | $3.02M | $87.93K | (m) | $19.77M | (m) | $436.94K | (m) | (m) | 14.85% | 6.92× |
| 2015-02-28 | $1.86M | (m) | $1.99M | $132.79K | (m) | $19.65M | (m) | $442.68K | (m) | (m) | 9.45% | 4.50× |
| 2014-11-30 | $1.43M | (m) | $1.55M | $120.52K | (m) | $20.13M | (m) | $553.62K | (m) | (m) | 7.13% | 2.81× |
| 2014-08-31 | $1.09M | (m) | $1.29M | $203.88K | (m) | $19.86M | (m) | $682.11K | (m) | (m) | 5.47% | 1.89× |
| 2014-05-31 | $-98.61K | (m) | $94.34K | $192.95K | (m) | $19.75M | (m) | $639.97K | (m) | (m) | -0.50% | 0.15× |
| 2014-02-28 | $-73.91K | (m) | $209.61K | $283.52K | (m) | $19.72M | (m) | $180.54K | (m) | (m) | -0.37% | 1.16× |
| 2013-11-30 | $472.20K | (m) | $821.98K | $349.78K | (m) | $18.99M | (m) | $27.44K | (m) | (m) | 2.49% | 29.96× |
| 2013-08-31 | $929.89K | (m) | $1.17M | $235.24K | (m) | $19.11M | (m) | $-659.60K | (m) | (m) | 4.87% | -1.77× |
| 2013-05-31 | $1.64M | (m) | $1.88M | $247.38K | (m) | $18.82M | (m) | $-1.40M | (m) | (m) | 8.70% | -1.35× |
| 2013-02-28 | $577.08K | (m) | $708.67K | $131.59K | (m) | $18.39M | (m) | $-4.38M | (m) | (m) | 3.14% | -0.16× |
| 2012-11-30 | $227.36K | (m) | $360.90K | $133.54K | (m) | $17.97M | (m) | $-6.31M | (m) | (m) | 1.27% | -0.06× |
| 2012-08-31 | $316.03K | (m) | $398.98K | $82.95K | (m) | $17.58M | (m) | $-5.58M | (m) | (m) | 1.80% | -0.07× |
| 2012-05-31 | $-64.26K | (m) | $195.60K | $259.86K | (m) | $17.45M | (m) | $-7.41M | (m) | (m) | -0.37% | -0.03× |
| 2012-02-29 | $383.92K | (m) | $739.27K | $355.35K | (m) | $17.62M | (m) | $-4.01M | (m) | (m) | 2.18% | -0.18× |
| 2011-11-30 | $313.41K | (m) | $819.12K | $505.71K | (m) | $17.92M | (m) | $-2.10M | (m) | (m) | 1.75% | -0.39× |
| 2011-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-11-30 | $1.94M | (m) | $2.34M | $398.90K | (m) | $17.76M | (m) | $3.46M | (m) | (m) | 10.92% | 0.67× |
| 2010-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |